Topics
January/February 2016 | Special Focus: Inside The Treatment Pipeline
Reversing Retinal Ischemia
Using encapsulated cell technology, a novel device may some day be used to treat inadequate oxygenation associated with common diseases.
Logan Christensen, MD, and Jeffrey L. Olson, MD
May 21, 2026
Lexitas Pharma Services Acquires Erie Retina Research, CASExERIE, and Element Erie Assets
May 19, 2026
Aflibercept Biosimilars Ahzantive and Baiama Now Available in the European Union
Bausch + Lomb Launches PreserVision AREDS3 Eye Vitamins in US
May 18, 2026
Optivate Appoints Brad Caldwell as Chief Executive Officer
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar